Groups with limited or no safety data Published human trials with AOD-9604 enrolled adults with obesity (BMI 30-45 kg/m^2), generally aged 18-65
The most common symptoms include: Episodes of severe, shooting or jabbing pain that may feel like an electric shock on one side of your face Pain thats triggered by touch, movement, chewing, brushing your teeth, shaving, talking or smiling Pain that lasts from a few seconds to several minutes and may occur several times a day or in clusters Pain that spreads to other areas of your face or head Pain thats accompanied by muscle spasms, twitching or tearing of the eye Pain that varies in intensity, frequency and duration Pain that worsens over time Pain and discomfort that becomes more resistant to trigeminal neuralgia treatments Whos at Risk of Developing Facial Pain
PMID: 38980576 | doi:10.1007/s10787-024-01499-8 Yarmola EG et al
Full AI Image Prompt: Create a clean medical editorial infographic titled GHK-Cu Evidence Landscape. Design a vertical evidence ladder with five labeled rows: Topical photoaging, Diabetic ulcer wound studies, Skin permeation and formulation research, Hair growth models, and Injectable safety context. Add small columns or badges for Clinical or early human, Preclinical, and Regulatory safety context. Include neutral text snippets such as formulation matters, study context only, and not a guaranteed outcome. Use white background, clear typography, subtle blue, gray, and copper accents
Maintenance fit long-running protocols usually work better as a cadence than as daily pressure forever
GHK-Cu Copper tripeptide (1% solution) 11,70 53,10 Bis(tripeptide-1) copper acetate 1% aqueous solution is intended for the production of cosmetics and the enrichment of formulas